ArticlePloS one2026
Intelligent diagnosis of major depressive disorder with edge convolution and contrastive learning.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Based on functional connectivity (FC) matrices derived from resting-state functional magnetic resonance imaging (rs-fMRI) data, graph neural networks (GNNs), as an advanced deep learning technique, have been widely applied in major depressive disorder (MDD) diagnosis. However, conventional GNNs suffer from a critical limitation in preserving the spatial specificity of brain regions, which is attributed to their intrinsic node permutation invariance that ignores the unique order and specific roles of brain regions in neural circuits. To address this limitation, in this paper, we propose a novel deep learning framework, Graph Contrastive Learning based on Edge Convolution (EC-GCL), to analyze resting-state fMRI data from 1,160 participants, including 597 patients with MDD and 563 healthy controls. This framework integrates an edge convolution encoder, specifically designed to preserve the spatial specificity of brain regions, with a learnable graph augmentation module into an adversarial graph contrastive learning, thereby enhancing the extraction of discriminative MDD-related FC features and improving diagnostic classification accuracy. Compared with conventional machine learning and GNN models, our proposed EC-GCL achieved superior performance (AUC = 71.2%) and improved interpretability. In particular, the framework identified several key brain regions, including the dorsolateral superior frontal gyrus, thalamus, and insula, that are closely linked to the pathophysiology of MDD, which is consistent with the findings of prior neuroimaging studies. This study demonstrates that combining edge convolution with contrastive learning provides a robust and explainable method for MDD diagnosis. This provides new insights into depression and may support improvements in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.